Prof Ian Smith MD, Marion Procter MSci, Prof Richard D Gelber PhD, Sébastien Guillaume MSc, Andrea Feyereislova MD, Prof Mitch Dowsett PhD, Prof Aron Goldhirsch MD, Prof Michael Untch MD, Gabriella Mariani MD, Prof Jose Baselga MD, Prof Manfred Kaufmann MD, David Cameron MD, Prof Richard Bell MD, Prof Jonas Bergh MD, Prof Robert Coleman MD, Andrew Wardley MD, Prof Nadia Harbeck MD, Roberto I Lopez MD, Prof Peter Mallmann MD, Prof Karen Gelmon MD, Nicholas Wilcken PhD, Prof Erik Wist PhD, Pedro Sánchez Rovira MD, Prof Martine J Piccart-Gebhart MD, for the HERA study team. 2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial. The Lancet 2007; 369: 29-36.
Para más información vaya al siguiente enlace:
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(07)60028-2/abstract